BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38459814)

  • 1. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
    Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
    Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
    Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
    Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
    Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
    Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL
    Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
    Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
    Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
    Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
    Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis.
    Suda K; Cruz Diaz LA; Yoshihara K; Nakaoka H; Yachida N; Motoyama T; Inoue I; Enomoto T
    Cancer Sci; 2020 Aug; 111(8):3000-3009. PubMed ID: 32473611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
    Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis.
    Yuwono NL; Alonso A; Abbott J; Houshdaran S; Henry CE; Rodgers R; Ford CE; Warton K
    Hum Reprod; 2022 Oct; 37(11):2560-2569. PubMed ID: 36166696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Implications for Patients with Endometriosis.
    Wilbur MA; Shih IM; Segars JH; Fader AN
    Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
    Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
    J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
    N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESHRE guideline: endometriosis.
    Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
    Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMAC tumor supressor gene expression in ovarian endometriosis and ovarian adenocarcinoma.
    Cirpan T; Aygul S; Terek MC; Kazandi M; Dikmen Y; Zekioglu O; Sagol S
    Eur J Gynaecol Oncol; 2007; 28(4):278-81. PubMed ID: 17713092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
    Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
    Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
    Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL
    Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.